Nurix Therapeutics (NRIX) Shares Outstanding (Diluted) (2020 - 2026)
Nurix Therapeutics (NRIX) recorded Weighted Average Shares Outstanding (Diluted) of 116.15 million in fiscal Q3 2026 (quarter ended Aug 31, 2026), up 38.0% from 84.16 million a year earlier and up 4.6% from the prior quarter.
Powered by 
Analysis
Nurix Therapeutics (NRIX) Shares Outstanding (Diluted) (2020 - 2026) Analysis & Trends
For FY2025 (ended Nov 30, 2025), Nurix Therapeutics reported Weighted Average Shares Outstanding (Diluted) of 86.67 million, up 29.1% from FY2024.
- Annual Weighted Average Shares Outstanding (Diluted) has increased for five straight fiscal years, with a five-year compound annual growth rate of 38.6% (FY2020 to FY2025).
- Across earlier fiscal years, Weighted Average Shares Outstanding (Diluted) came in at 67.12 million in FY2024 (+23.5%), 54.34 million in FY2023 (+11.8%), 48.61 million in FY2022 (+13.3%) and 42.9 million in FY2021 (+153.3%).
- The fiscal Q3 2026 figure is the highest quarterly Weighted Average Shares Outstanding (Diluted) in data going back to fiscal Q2 2020.
- On a year-over-year basis, Weighted Average Shares Outstanding (Diluted) has increased for 22 consecutive quarters, with growth averaging 32.1% over the last eight quarters.
- The year-over-year growth in Weighted Average Shares Outstanding (Diluted) has ranged between 1.6% (fiscal Q1 2024) and 163.9% (fiscal Q1 2022) over the last five years.
- Per Business Quant, the preceding three fiscal quarters came in at 111.08 million (Q2 2026), 110.07 million (Q1 2026) and 86.67 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 893.40 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 2.45 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 1.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 2.48 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 1.96 Bn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 1.56 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 546.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.25 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 5.75 Bn |
| 10 | Nurix Therapeutics | 1.73 Bn | -891.35 Mn | - | 116.15 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Aug 31, 2026 | 116.15 Mn |
| May 31, 2026 | 111.08 Mn |
| Feb 28, 2026 | 110.07 Mn |
| Nov 30, 2025 | 86.67 Mn |
| Aug 31, 2025 | 84.16 Mn |
| May 31, 2025 | 83.88 Mn |
| Feb 28, 2025 | 83.56 Mn |
| Nov 30, 2024 | 67.12 Mn |
| Aug 31, 2024 | 72.78 Mn |
| May 31, 2024 | 62.38 Mn |
| Feb 29, 2024 | 54.90 Mn |
| Nov 30, 2023 | 54.34 Mn |
| Aug 31, 2023 | 54.39 Mn |
| May 31, 2023 | 54.26 Mn |
| Feb 28, 2023 | 54.03 Mn |
| Nov 30, 2022 | 48.61 Mn |
| Aug 31, 2022 | 50.87 Mn |
| May 31, 2022 | 44.90 Mn |
| Feb 28, 2022 | 44.69 Mn |
| Nov 30, 2021 | 42.90 Mn |
API Access
Nurix Therapeutics Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=NRIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "NRIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=NRIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();